Peter M. Wehmeier

2.2k total citations · 1 hit paper
36 papers, 1.7k citations indexed

About

Peter M. Wehmeier is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cognitive Neuroscience. According to data from OpenAlex, Peter M. Wehmeier has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Psychiatry and Mental health, 13 papers in Clinical Psychology and 5 papers in Cognitive Neuroscience. Recurrent topics in Peter M. Wehmeier's work include Schizophrenia research and treatment (12 papers), Attention Deficit Hyperactivity Disorder (11 papers) and Child and Adolescent Psychosocial and Emotional Development (8 papers). Peter M. Wehmeier is often cited by papers focused on Schizophrenia research and treatment (12 papers), Attention Deficit Hyperactivity Disorder (11 papers) and Child and Adolescent Psychosocial and Emotional Development (8 papers). Peter M. Wehmeier collaborates with scholars based in Germany, United States and United Kingdom. Peter M. Wehmeier's co-authors include Alexander Schacht, Russell A. Barkley, Helmut Remschmidt, Regina Dittmann, Michael Kluge, Andreas Schuld, Mira Dalal, Thomas Kraus, Dunja Hinze‐Selch and Johannes Hebebrand and has published in prestigious journals such as PEDIATRICS, Psychoneuroendocrinology and Journal of Adolescent Health.

In The Last Decade

Peter M. Wehmeier

34 papers receiving 1.6k citations

Hit Papers

Social and Emotional Impairment in Children and Adolescen... 2010 2026 2015 2020 2010 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter M. Wehmeier Germany 21 1.1k 594 370 197 149 36 1.7k
Chih‐Ken Chen Taiwan 24 793 0.7× 399 0.7× 438 1.2× 174 0.9× 101 0.7× 71 1.7k
Christian Fleischhaker Germany 26 969 0.9× 982 1.7× 338 0.9× 103 0.5× 65 0.4× 83 1.8k
Sam Tyano Israel 24 824 0.7× 907 1.5× 289 0.8× 127 0.6× 117 0.8× 72 2.0k
In‐Kwa Jung South Korea 25 674 0.6× 361 0.6× 249 0.7× 175 0.9× 42 0.3× 55 1.6k
Avner Elizur Israel 23 521 0.5× 450 0.8× 265 0.7× 248 1.3× 44 0.3× 53 1.4k
Anne Halmøy Norway 24 1.5k 1.4× 425 0.7× 772 2.1× 228 1.2× 214 1.4× 54 2.0k
Covadonga M. Díaz‐Caneja Spain 24 1.1k 1.0× 749 1.3× 447 1.2× 202 1.0× 56 0.4× 95 2.2k
Arthur Kaladjian France 27 1.1k 1.0× 627 1.1× 485 1.3× 312 1.6× 63 0.4× 119 1.9k
Adelaide S. Robb United States 24 1.6k 1.4× 989 1.7× 437 1.2× 132 0.7× 107 0.7× 74 2.2k
Miguel Ruíz-Veguilla Spain 22 1.1k 1.0× 673 1.1× 263 0.7× 195 1.0× 47 0.3× 107 1.7k

Countries citing papers authored by Peter M. Wehmeier

Since Specialization
Citations

This map shows the geographic impact of Peter M. Wehmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Wehmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Wehmeier more than expected).

Fields of papers citing papers by Peter M. Wehmeier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. Wehmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Wehmeier. The network helps show where Peter M. Wehmeier may publish in the future.

Co-authorship network of co-authors of Peter M. Wehmeier

This figure shows the co-authorship network connecting the top 25 collaborators of Peter M. Wehmeier. A scholar is included among the top collaborators of Peter M. Wehmeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter M. Wehmeier. Peter M. Wehmeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kluge, Michael, Alexander Schacht, Hubertus Himmerich, et al.. (2013). Olanzapine and clozapine differently affect sleep in patients with schizophrenia: Results from a double-blind, polysomnographic study and review of the literature. Schizophrenia Research. 152(1). 255–260. 29 indexed citations
2.
Kluge, Michael, Hubertus Himmerich, Peter M. Wehmeier, et al.. (2012). Sleep propensity at daytime as assessed by Multiple Sleep Latency Tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine. Schizophrenia Research. 135(1-3). 123–127. 16 indexed citations
3.
Dittmann, Regina, Alexander Schacht, Karin Helsberg, et al.. (2011). Atomoxetine Versus Placebo in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder: A Double-Blind, Randomized, Multicenter Trial in Germany. Journal of Child and Adolescent Psychopharmacology. 21(2). 97–110. 36 indexed citations
5.
Wehmeier, Peter M., Alexander Schacht, Regina Dittmann, & Tobias Banaschewski. (2010). Minor differences in ADHD-related difficulties between boys and girls treated with atomoxetine for attention-deficit/hyperactivity disorder. ADHD Attention Deficit and Hyperactivity Disorders. 2(2). 73–85. 6 indexed citations
6.
Wehmeier, Peter M., Regina Dittmann, Alexander Schacht, Karin Helsberg, & Gerd Lehmkuhl. (2009). Morning and evening behavior in children and adolescents treated with atomoxetine once daily for Attention-Deficit/Hyperactivity Disorder (ADHD): Findings from two 24-week, open-label studies. Child and Adolescent Psychiatry and Mental Health. 3(1). 5–5. 24 indexed citations
7.
Gebhardt, G., Frank Theisen, Michael Haberhausen, et al.. (2009). Body weight gain induced by atypical antipsychotics: an extension of the monocygotic twin and sib pair study. Journal of Clinical Pharmacy and Therapeutics. 35(2). 207–211. 72 indexed citations
8.
Dittmann, Regina, Franz Joseph Freisleder, Helmut Remschmidt, et al.. (2008). Effectiveness and Tolerability of Olanzapine in the Treatment of Adolescents with Schizophrenia and Related Psychotic Disorders: Results from a Large, Prospective, Open-Label Study. Journal of Child and Adolescent Psychopharmacology. 18(1). 54–69. 29 indexed citations
9.
10.
Kluge, Michael, Andreas Schuld, Alexander Schacht, et al.. (2008). Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. Psychoneuroendocrinology. 34(1). 118–128. 119 indexed citations
11.
Lambert, Martin, Benno G. Schimmelmann, Alexander Schacht, et al.. (2008). Long-term patterns of subjective wellbeing in schizophrenia: Cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 years. Schizophrenia Research. 107(2-3). 165–172. 37 indexed citations
12.
Wehmeier, Peter M., Regina Dittmann, Alexander Schacht, et al.. (2007). Effectiveness of Atomoxetine and Quality of Life in Children with Attention-Deficit/Hyperactivity Disorder as Perceived by Patients, Parents, and Physicians in an Open-Label Study. Journal of Child and Adolescent Psychopharmacology. 17(6). 813–830. 24 indexed citations
13.
Wehmeier, Peter M., Michael Kluge, Alexander Schacht, et al.. (2007). Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia. Journal of Psychiatric Research. 42(8). 676–683. 12 indexed citations
14.
Wehmeier, Peter M., Michael Kluge, Edith Schneider, et al.. (2007). Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(3). 703–712. 38 indexed citations
15.
Kluge, Michael, Andreas Schuld, Hubertus Himmerich, et al.. (2007). Clozapine and Olanzapine Are Associated With Food Craving and Binge Eating. Journal of Clinical Psychopharmacology. 27(6). 662–666. 138 indexed citations
16.
Wehmeier, Peter M., G. Gebhardt, Jörg Schmidtke, et al.. (2005). Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation. Psychiatry Research. 133(2-3). 273–276. 58 indexed citations
17.
Wehmeier, Peter M., Philip Heiser, & Helmut Remschmidt. (2005). Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine. Journal of Clinical Pharmacy and Therapeutics. 30(1). 91–96. 59 indexed citations
18.
Wehmeier, Peter M., et al.. (2004). Chart Review for Potential Features of Myocarditis, Pericarditis, and Cardiomyopathy in Children and Adolescents Treated with Clozapine. Journal of Child and Adolescent Psychopharmacology. 14(2). 267–271. 20 indexed citations
19.
Wehmeier, Peter M., Nikolaus Barth, & Helmut Remschmidt. (2003). Induced Delusional Disorder. Psychopathology. 36(1). 37–45. 30 indexed citations
20.
Wehmeier, Peter M., et al.. (2001). Body image assessment using body size estimation in recent studies on anorexia nervosa. A brief review.. European Child & Adolescent Psychiatry. 10(4). 215–221. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026